Search

Search bills, members, committees and pages...

CHRISTINA INGRAM

14 federal lobbying filings, 2023 to 2026.

CHRISTINA INGRAM is a registered lobbyist named on 14 federal lobbying filings, 2023 to 2026.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

1 they have filed under, by filings.

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262$500K
20254$940K
20244$820K
20234$1.2M

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
BUDBudget/Appropriations14
HCRHealth Issues14
TAXTaxation/Internal Revenue Code4

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 5461Special Diabetes Program Reauthorization Act of 20253
H.R. 5467PAAT Act3
S. 2211Special Diabetes Program Reauthorization Act of 20253
H.R. 4121Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 20262
H.R. 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 20262
H.R. 5371Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and E…2
H.R. 5488Special Diabetes Program for Indians Reauthorization Act of 20252
H.R. 801Charitable Act2
H.R. 8018ISLET Act2
S. 2587Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 20262
S. 317Charitable Act2
S. 4189INSULIN Act of 20262
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.1
H.R. 1539Medical Device Electronic Labeling Act1
H.R. 1968Full-Year Continuing Appropriations and Extensions Act, 20251
H.R. 3826Expanding Access to Diabetes Self-Management Training Act of 20251
H.R. 7148Consolidated Appropriations Act, 20261
H.R. 8646Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 20271
H.R. 9000SCREEN for Type 1 Diabetes Act of 20261
H.R. 919Chronic Disease Flexible Coverage Act1
H.R. 9620Military Next-Gen Collision Avoidance Act of 20261
S. 1925Expanding Access to Diabetes Self-Management Training Act of 20251
S. 2256Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 20261
S. 3064Relief of Chronic Pain Act of 20251
S. 3105ISLET Act1

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)2026 second_quarter$220KJul 20, 2026
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)2026 first_quarter$280KApr 20, 2026
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)2025 fourth_quarter$290KJan 20, 2026
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)2025 third_quarter$300KOct 20, 2025
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)2025 second_quarter$160KJul 21, 2025
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)2025 first_quarter$190KApr 21, 2025
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)2024 fourth_quarter$180KJan 21, 2025
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)2024 third_quarter$140KOct 21, 2024
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)2024 second_quarter$370KJul 22, 2024
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)2024 first_quarter$130KApr 23, 2024
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)2023 fourth_quarter$340KJan 22, 2024
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)2023 third_quarter$300KOct 20, 2023
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)2023 second_quarter$220KJul 20, 2023
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)2023 first_quarter$330KApr 20, 2023